Dellamonica P - Search Results

1

Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.

Garraffo R, Iliadis A, Cano JP, Dellamonica P, Lapalus P. Garraffo R, et al. Among authors: dellamonica p. J Pharm Sci. 1989 Sep;78(9):753-7. doi: 10.1002/jps.2600780911. J Pharm Sci. 1989. PMID: 2585270

2

Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.

Garraffo R, Drugeon HB, Dellamonica P, Bernard E, Lapalus P. Garraffo R, et al. Among authors: dellamonica p. Antimicrob Agents Chemother. 1990 Apr;34(4):614-21. doi: 10.1128/AAC.34.4.614. Antimicrob Agents Chemother. 1990. PMID: 2111658 Free PMC article. Clinical Trial.

3

A new approach to optimal antibiotic dosage regimen by coupling pharmacokinetics and killing curve parameters.

Garraffo R, Dellamonica P, Drugeon HB, Etesse H, Lapalus P. Garraffo R, et al. Among authors: dellamonica p. Methods Find Exp Clin Pharmacol. 1990 Jun;12(5):325-32. Methods Find Exp Clin Pharmacol. 1990. PMID: 2146452 Clinical Trial.

4

Evaluation of a microbiological method for zidovudine blood level determination.

Etesse-Carsenti H, Carles M, Diquet B, Garraffo R, Mondain V, Bernard E, Dellamonica P. Etesse-Carsenti H, et al. Among authors: dellamonica p. AIDS. 1990 Mar;4(3):265. AIDS. 1990. PMID: 2190600 No abstract available.

5

Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.

Dellamonica P, Bernard E, Etesse H, Garraffo R, Drugeon HB. Dellamonica P, et al. Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1024-30. doi: 10.1007/BF01975163. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2515961

6

Fetoplacental passage of zidovudine.

Gillet JY, Garraffo R, Abrar D, Bongain A, Lapalus P, Dellamonica P. Gillet JY, et al. Among authors: dellamonica p. Lancet. 1989 Jul 29;2(8657):269-70. doi: 10.1016/s0140-6736(89)90449-2. Lancet. 1989. PMID: 2569069 No abstract available.

7

Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.

Garraffo R, Dellamonica P, Bernard E, Etesse H, Lapalus P. Garraffo R, et al. Among authors: dellamonica p. Int J Clin Pharmacol Res. 1989;9(1):29-35. Int J Clin Pharmacol Res. 1989. PMID: 2707923 Clinical Trial.

8

[Kinetics of pefloxacin diffusion in human bone tissue following a single infusion of 800 mg. Evaluation of an extraction technic using chloroform].

Etesse-Carsenti H, Garraffo R, Giaume F, Barbarin A, Bernard E, Lapalus P, Argenson C, Drugeon HB, Dellamonica P. Etesse-Carsenti H, et al. Among authors: dellamonica p. Pathol Biol (Paris). 1988 Jun;36(5 Pt 2):715-8. Pathol Biol (Paris). 1988. PMID: 3054753 French.

9

The diffusion of pefloxacin into bone and the treatment of osteomyelitis.

Dellamonica P, Bernard E, Etesse H, Garraffo R. Dellamonica P, et al. J Antimicrob Chemother. 1986 Apr;17 Suppl B:93-102. doi: 10.1093/jac/17.suppl_b.93. J Antimicrob Chemother. 1986. PMID: 3086280

10

[Bone infections: treatment by ofloxacin. Apropos of 10 cases].

Bernard E, Etesse H, Garraffo R, Giaume F, Dellamonica P. Bernard E, et al. Among authors: dellamonica p. Pathol Biol (Paris). 1987 May;35(5):644-7. Pathol Biol (Paris). 1987. PMID: 3302877 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters